Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Lymphoma 2010 NCI 5R01CA076287-12 Pretargeted Radioimmunotherapy of CD20+ Lymphomas PRESS, OLIVER FRED HUTCHINSON CANCER RESEARCH CENTER WA $364,467
Lymphoma 2010 NCI 7R01CA116093-04 Effects of human SWI/SNF-associated PRMT5 on lymphomagenesis SIF, SAID OHIO STATE UNIVERSITY OH $256,500
Lymphoma 2010 NIAID 5R01AI079732-08 Accessibility Control of Antigen Receptor Gene Assembly OLTZ, EUGENE WASHINGTON UNIVERSITY MO $376,200
Lymphoma 2010 NCI 5R01CA100603-08 Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer CLEVELAND, JOHN SCRIPPS RESEARCH INSTITUTE CA $422,647
Lymphoma 2010 NCI 5R01CA077429-11 Basis for Lymphomagenesis in Akt2 Transgenic Mice TESTA, JOSEPH FOX CHASE CANCER CENTER PA $452,084
Lymphoma 2010 NCI 5R01CA124621-04 Role of Arsenic Trioxide in Primary Effusion Lymphoma CHAUDHARY, PREET UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $12,225
Lymphoma 2010 NCI 5R01CA031534-26 MAR Mediated Control of The IgH Enhancer TUCKER, PHILIP UNIVERSITY OF TEXAS AUSTIN TX $257,359
Lymphoma 2010 NCI 5R01CA096856-07 Novel role of STAT3 in NPM/ALK-induced oncogenesis WASIK, MARIUSZ UNIVERSITY OF PENNSYLVANIA PA $299,362
Lymphoma 2010 NCI 5R01CA078384-12 E2A as a Tumor Suppressor MURRE, CORNELIS UNIVERSITY OF CALIFORNIA SAN DIEGO CA $410,326
Lymphoma 2010 NCI 5R01CA131354-02 Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $369,350
Lymphoma 2010 NCI 5R21CA133781-02 DNA Damage Responses in B Cell Development MANIS, JOHN CHILDREN'S HOSPITAL BOSTON MA $186,235
Lymphoma 2010 NCI 5R01CA073507-13 In Vivo Model of Epstein-Barr Virus Latency LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY IL $499,500
Lymphoma 2010 NCI 5R01CA137894-02 EBV Antigen and Cell Cycle Regulation ROBERTSON, ERLE UNIVERSITY OF PENNSYLVANIA PA $294,131
Lymphoma 2010 NCI 5R01CA122539-03 Lymphoproliferative Disorders in Primary Immunodeficiencies ROUTES, JOHN MEDICAL COLLEGE OF WISCONSIN WI $314,363
Lymphoma 2010 NIDDK 5K01DK080894-03 DNA EXCHANGE DURING STOMACH COLONIZATION BY HELICOBACTER PYLORI DORER, MARION FRED HUTCHINSON CANCER RESEARCH CENTER WA $102,604
Lymphoma 2010 NCI 5R01CA119917-03 Studying the role of KSHV-encoded microRNAs RENNE, ROLF UNIVERSITY OF FLORIDA FL $297,147
Lymphoma 2010 NCI 5R01CA130752-03 Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $309,175
Lymphoma 2010 NCI 5R01CA070723-14 Genetic Analysis of EBV's Immortalizing Genes SUGDEN, WILLIAM UNIVERSITY OF WISCONSIN MADISON WI $293,829
Lymphoma 2010 NCI 5R01CA133027-03 EBV's Plasmid Replicon: Its Synthesis, Partitioning, and Maintenance of Tumors SUGDEN, WILLIAM UNIVERSITY OF WISCONSIN MADISON WI $300,378
Lymphoma 2010 NCI 5R37CA042245-25 Regulation of replication and latency EBV EBNAs HAYWARD, S JOHNS HOPKINS UNIVERSITY MD $330,635
Lymphoma 2010 NCI 5R01CA066519-16 EBV-based Strategies for AIDS-related Malignancies KENNEY, SHANNON UNIVERSITY OF WISCONSIN MADISON WI $386,535
Lymphoma 2010 NIAID 5R01AI063345-05 Trophic Regulation in T Cell Homeostasis and Disease RATHMELL, JEFFREY DUKE UNIVERSITY NC $367,781
Lymphoma 2010 NCI 5R01CA102705-07 Mismatch repair in V region mutation and isotype switching SCHARFF, MATTHEW ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $324,645
Lymphoma 2010 NCI 5R01CA132840-02 Function of REV3L in limiting oncogenesis via DNA damage tolerance WOOD, RICHARD UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $319,550
Lymphoma 2010 NCI 5R01CA033192-23 Transformation by Reticuloendotheliosis Virus BOSE, HENRY UNIVERSITY OF TEXAS AUSTIN TX $302,222
Lymphoma 2010 NCI 5R01CA124332-04 Regulation of KSHV infection and replication by MAPK pathways GAO, SHOU-JIANG UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT TX $277,400
Lymphoma 2010 NCI 5R00CA126186-04 Functions of microRNAs in lymphomagenesis HE, LIN UNIVERSITY OF CALIFORNIA BERKELEY CA $246,721
Lymphoma 2010 NCI 5R01CA093237-09 Nuclear Accumulation of Cyclin D1 and Oncogenesis DIEHL, JOHN UNIVERSITY OF PENNSYLVANIA PA $291,081
Lymphoma 2010 NIAID 5R01AI018757-28 Host Immunity to EBV Infection in Vitro and in VIvo THORLEY-LAWSON, DAVID TUFTS UNIVERSITY BOSTON MA $408,375
Lymphoma 2010 NCI 5R01CA116933-04 Preventing Tumorigenesis in Developing Lymphocytes ZHU, CHENGMING UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $292,600
Lymphoma 2010 NCI 5R01CA119066-05 Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2 LOOK, A DANA-FARBER CANCER INSTITUTE MA $303,525
Lymphoma 2010 NCI 5R01CA125658-04 Rac GTPases as Targets in Lymphomagenesis ZHENG, YI CHILDREN'S HOSPITAL MED CTR (CINCINNATI) OH $285,000
Lymphoma 2010 NCI 5R01CA052004-21 Control of Gammaherpesvirus Replication SPECK, SAMUEL EMORY UNIVERSITY GA $320,153
Lymphoma 2010 NCI 5R01CA117935-04 p53-Independent Pathways in Mdm2-Mediated Transformation EISCHEN, CHRISTINE VANDERBILT UNIVERSITY TN $290,620
Lymphoma 2010 NCI 5F32CA132350-02 Coordinate Suppression of B Cell Lymphoma by PTEN and SHIP MILETIC SEDY, ANA SANFORD-BURNHAM MEDICAL RESEARCH INSTIT CA $52,154
Lymphoma 2010 NHLBI 5K08HL091517-03 Annexin 2 in Lymphoproliferative Angiogenesis RUAN, JIA WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $131,490
Lymphoma 2010 NCI 5R37CA012055-38 Studies of Epstein-Barr Virus MILLER, I. YALE UNIVERSITY CT $461,604
Lymphoma 2010 NCI 5R01CA071540-13 Molecular Basis of Action of the Putative Oncogene BCL-6 BARDWELL, VIVIAN UNIVERSITY OF MINNESOTA TWIN CITIES MN $311,085
Lymphoma 2010 NCI 1R01CA142664-01 Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks. YOTNDA, PATRICIA BAYLOR COLLEGE OF MEDICINE TX $318,513
Lymphoma 2010 NCI 5R01CA120185-04 c-Myc-regulated microRNAs in normal and pathologic cellular physiology MENDELL, JOSHUA JOHNS HOPKINS UNIVERSITY MD $309,168
Lymphoma 2010 NCI 1R01CA142798-01 The contribution of protein translation to tumorigenesis WENDEL, HANS-GUIDO SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $394,250
Lymphoma 2010 NCI 5R01CA085573-10 Role of the BCL 6 Proto Oncogene in B Cell Lymphomas YE, BIHUI ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $364,967
Lymphoma 2010 NCI 5R01CA129132-03 Development of cambinol analogues as antilymphoma agents BEDALOV, ANTONIO FRED HUTCHINSON CANCER RESEARCH CENTER WA $365,200
Lymphoma 2010 NCI 5R37CA054281-18 Multiethnic Cohort Study of Diet and Cancer KOLONEL, LAURENCE UNIVERSITY OF HAWAII AT MANOA HI $2,366,455
Lymphoma 2010 NCI 1R01CA143032-01 Molecular Targeting of Diffuse Large B-cell Lymphoma MELNICK, ARI WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $633,103
Lymphoma 2010 NCI 5R01CA132638-03 Anti-viral IL6 approach to mitigate KSHV-related disease WONG, SCOTT OREGON HEALTH AND SCIENCE UNIVERSITY OR $642,809
Lymphoma 2010 NCI 5R01CA089305-09 MYC's Role in the Initiation and Maintenance of Cancer FELSHER, DEAN STANFORD UNIVERSITY CA $399,339
Lymphoma 2010 NCI 5R03CA135687-02 Vitamin D, alcohol, and risk of lymphomas in a prospective cohort of women CHANG, ELLEN CANCER PREVENTION INSTIT OF CALIFORNIA CA $72,500
Lymphoma 2010 NCI 5R01CA101700-06 1H NMR STUDIES OF NON-HODGKINS LYMPHOMA GLICKSON, JERRY UNIVERSITY OF PENNSYLVANIA PA $364,626
Lymphoma 2010 NCI 5R01CA121180-05 A Comprehensive Investigation of Viral-induced Lymphomagenesis FISHER, SUSAN UNIVERSITY OF ROCHESTER NY $268,056
Lymphoma 2010 NCI 5R01CA136895-02 Molecular targets in diffuse large B cell lymphoma DAVE, SANDEEP DUKE UNIVERSITY NC $258,960
Lymphoma 2010 NHLBI 5F30HL095287-02 Infection of primary B cells by the human lymphomagenic pathogen HHV8 HASSMAN, LYNN UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $48,717
Lymphoma 2010 NIAID 5R21AI082329-02 A novel method to identify interacting partners of insoluble proteins PAPAVASILIOU, F. ROCKEFELLER UNIVERSITY NY $209,138
Lymphoma 2010 NCI 1K08CA143151-01 Role of Sonic Hedgehog Signaling Pathway in Diffuse Large B-Cell Lymphoma VEGA-VAZQUEZ, FRANCISCO UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $170,640
Lymphoma 2010 NIAID 1R03AI085545-01 A FUNCTIONAL STUDY OF UBIQUITIN C-TERMINAL HYDROLASE L1 EXPRESSION IN B-LYMPHOMA SHACKELFORD, JULIA UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $74,000
Lymphoma 2010 NIAID 5R01AI068907-03 Transcriptional Control of Th-POK, a Key Regulator of Lineage Control KAPPES, DIETMAR INSTITUTE FOR CANCER RESEARCH PA $501,337
Lymphoma 2010 NCI 5R01CA124311-04 Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300 FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $254,790
Lymphoma 2010 NIAID 5R01AI060729-06 Stage-specific Signaling in Peripheral B Cell Selection KHAN, WASIF UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $360,708
Lymphoma 2010 NCI 5R01CA129560-02 Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas HAQUE, AZIZUL MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $303,106
Lymphoma 2010 NCI 5R01CA117827-06 Function of the Epstein-Barr Virus EBNA-A3 Protein SAMPLE, CLARE PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $251,176
Lymphoma 2010 NIDCR 5F31DE019599-02 Early events in infection of epithelial cells with Epstein-Barr Virus VALENCIA, SARAH LOUISIANA STATE UNIV HSC SHREVEPORT LA $26,639
Lymphoma 2010 NCI 5R01CA118559-04 IN VIVO 31P MRS STUDIES OF NON-HODGKIN'S LYMPHOMA BROWN, TRUMAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $1,222,597
Lymphoma 2010 NCI 1R01CA139319-01A1 The ARF Tumor Suppressor MURPHY, MAUREEN FOX CHASE CANCER CENTER PA $362,088
Lymphoma 2010 NIAID 5F32AI078625-02 Kaposi's Sarcoma-Associated Herpesvirus (KSHV) evasion of Natural Killer cells MADRID, ALEXIS UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $53,810
Lymphoma 2010 NCI 5R01CA099997-07 Mechanisms of Alteration of B Lymphocyte Function by LMP1 BISHOP, GAIL UNIVERSITY OF IOWA IA $333,785
Lymphoma 2010 NCI 5R01CA128941-03 Regulatory T cells in B cell lymphoma LEVITSKY, HYAM JOHNS HOPKINS UNIVERSITY MD $340,300
Lymphoma 2010 NCI 1R01CA138891-01A1 In vivo targeting of hematopoetic cells with glycan ligands of siglecs PAULSON, JAMES SCRIPPS RESEARCH INSTITUTE CA $396,086
Lymphoma 2010 NCI 2P01CA109901-06 7134 Mechanisms of Transformation by TAL1/SCL in Thymic Malignancy LOOK, A DANA-FARBER CANCER INSTITUTE MA $604,357
Lymphoma 2010 NCI 2P01CA109901-06 7135 Molecular Pathways in T Cell Development and T-ALL VON BOEHMER, HARALD DANA-FARBER CANCER INSTITUTE MA $212,292
Lymphoma 2010 NCI 2P01CA109901-06 7136 The Molecular Function of D-cyclins in T-ALL SICINSKI, PIOTR DANA-FARBER CANCER INSTITUTE MA $212,281
Lymphoma 2010 NCI 2P01CA109901-06 7137 Role of DNA Double Strand Break Response in Suppression of Thymic Lymphoma ALT, FREDERICK IMMUNE DISEASE INSTITUTE, INC. MA $447,050
Lymphoma 2010 NCI 2P01CA109901-06 7139 Administrative Core LOOK, A DANA-FARBER CANCER INSTITUTE MA $53,519
Lymphoma 2010 NCI 2P01CA109901-06 7140 Biostatistics and Bioinformatics Core NEUBERG, DONNA DANA-FARBER CANCER INSTITUTE MA $45,372
Lymphoma 2010 NCI 5R01CA098495-07 The Regulation of Somatic Hypermutation PAPAVASILIOU, F. ROCKEFELLER UNIVERSITY NY $274,395
Lymphoma 2010 NCI 2R01CA080320-11 Myc Oncogene Mutations and Polymorphisms in Cancer COLE, MICHAEL DARTMOUTH COLLEGE NH $347,191
Lymphoma 2010 NCI 2R01CA068051-15 Pathogenesis of EBV Infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $469,785
Lymphoma 2010 NCI 7R21CA135523-02 Cancer prevention by indole-3-carbinol via modulation of the epigenome BENNINGHOFF, ABBY UTAH STATE UNIVERSITY UT $184,800
Lymphoma 2010 NCI 1R01CA138636-01A1 BETR Therapy for Herpesvirus-Associated Tumors POMPER, MARTIN JOHNS HOPKINS UNIVERSITY MD $582,447
Lymphoma 2010 NCI 1R21CA143785-01 Enhancing antitumor immunity with anti-PD-1 antibody in follicular lymphoma. NEELAPU, SATTVA UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $288,425
Lymphoma 2010 NCI 5R01CA091791-09 Reactivation of Kaposi's sarcoma-associated herpesvirus SUN, REN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $281,463
Lymphoma 2010 NCI 1R21CA141324-01A1 Abrogating human CD59 activity for antibody-based cancer therapy QIN, XUEBIN HARVARD UNIVERSITY (MEDICAL SCHOOL) MA $184,331
Lymphoma 2010 NCI 5R01CA083937-08 Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis GELINAS, CELINE UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $58,188
Lymphoma 2010 NCI 1R01CA139389-01A1 Lymphoma Therapy with Reprogrammed Measles Viruses CATTANEO, ROBERTO MAYO CLINIC MN $313,533
Lymphoma 2010 NCI 1R21CA141275-01A1 Characterizing Clonogenic Populations in Mantle Cell Lymphoma MCCARTY, NAMI UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $163,125
Lymphoma 2010 NCI 5R01CA083823-09 Selective Forces Operative in FeLV Infection LEVY, LAURA TULANE UNIVERSITY OF LOUISIANA LA $268,650
Lymphoma 2010 NIGMS 5F32GM083438-03 Structural Analysis of DNA Replication Machinery of P. falciparum LINDNER, SCOTT SEATTLE BIOMEDICAL RESEARCH INSTITUTE WA $52,154
Lymphoma 2010 NIAID 4R37AI040227-15 Biochemistry and Regulation of V(D)J Recombination SCHLISSEL, MARK UNIVERSITY OF CALIFORNIA BERKELEY CA $419,005
Lymphoma 2010 NCI 1R01CA140806-01A1 Proteomic biomarkers of ALK+ lymphoma LIM, MEGAN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $320,588
Lymphoma 2010 FIC 5R03TW007821-03 Micronutrient Malnutrition and EBV Persistence in Children ROCHFORD, ROSEMARY UPSTATE MEDICAL UNIVERSITY NY $36,030
Lymphoma 2010 NIAID 5R03AI081021-02 Rapid FISH Detection of EBV-infected Cells STOWE, RAYMOND MICROGEN, LLC TX $76,725
Lymphoma 2010 NCI 5R01CA136905-02 Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma ELENITOBA-JOHNSON, KOJO UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $288,241
Lymphoma 2010 NCI 5R21CA138359-02 Ultrahigh sensitive, personalized monitoring of lymphoma relapse using blood spec YEN, YUN CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $182,600
Lymphoma 2010 NIAID 5R01AI076183-08 Structural and Functional Studies of gp42 and HLA Class II in EBV Entry LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY IL $411,741
Lymphoma 2010 NCI 5R01CA071796-13 Multistep Lymphomagenesis/Tumorigenesis in Transgenic Mice: Protein Kinase Ck2 SELDIN, DAVID BOSTON MEDICAL CENTER MA $275,767
Lymphoma 2010 NCI 5R01CA129682-02 Regulation of Autophagy and Tumorigenesis by Bif-1 WANG, HONG-GANG PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $321,833
Lymphoma 2010 NCI 5R01CA098285-07 Towards a Mouse Model of Classical Hodgkin's Disease and PTLD RAJEWSKY, KLAUS IMMUNE DISEASE INSTITUTE, INC. MA $494,023
Lymphoma 2010 NIAID 1R43AI081332-01A1 TARGETING THE B-CELL RECPTOR COMPLEX AND DOWNSTREATM KINASES WELT, SYDNEY WELT BIO-MOLECULAR PHARMACEUTICAL, LLC NY $127,330
Lymphoma 2010 NCI 5R01CA127238-04 Herpesvirus-induced telomerase dysregulation and tumor formation JAROSINSKI, KEITH CORNELL UNIVERSITY ITHACA NY $228,522
Lymphoma 2010 NCI 5R01CA117802-06 MYC-induced breach of B-cell anergy in AIDS-related NHLs REFAELI, YOSEF UNIVERSITY OF COLORADO DENVER CO $359,925
Lymphoma 2010 NIAID 5R01AI041769-13 Cellular Mechanisms of PTLD in Transplant Recipients MARTINEZ, OLIVIA STANFORD UNIVERSITY CA $411,227
Lymphoma 2010 NIA 5R01AG026661-05 Role of RecQ Helicases to Prevent Senescence By c-Myc GRANDORI, CARLA FRED HUTCHINSON CANCER RESEARCH CENTER WA $300,693
Lymphoma 2010 NCI 5R01CA134051-04 T Cell Immunity in Endemic Burkitt Lymphoma MOORMANN, ANN UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $465,952
Lymphoma 2010 NCI 1R42CA144104-01 Sideport Needle Array Technologies for Prioritizing Drugs for Cancer Patients OLSON, JAMES PRESAGE BIOSCIENCES, INC. CA $164,492
Lymphoma 2010 NIAID 5R01AI077533-02 Regulation of Immunity and Inflammation by TIPE2 CHEN, YOUHAI UNIVERSITY OF PENNSYLVANIA PA $389,813
Lymphoma 2010 NCI 5R01CA114416-05 Epstein-Barr Virus-Enhanced Tumor Progression SCOTT, RONA LOUISIANA STATE UNIV HSC SHREVEPORT LA $283,896
Lymphoma 2010 NCI 5R01CA137123-02 Tageting BAFF and BAFF-Induced Non-Canonical NF-kB Pathways for Enhancing Mantle TAO, JIANGUO H. LEE MOFFITT CANCER CTR & RES INST FL $277,220
Lymphoma 2010 NHLBI 5R01HL088686-03 Modeling B cell Lymphoma RICKERT, ROBERT SANFORD-BURNHAM MEDICAL RESEARCH INSTIT CA $477,500
Lymphoma 2010 NCI 5F31CA134209-03 microRNAs Dysregulated by HMG-I in Neoplastic Transformation SMAIL, SHAMAYRA JOHNS HOPKINS UNIVERSITY MD $41,380
Lymphoma 2010 NCI 5R21CA138373-02 Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago YIN, HANG UNIVERSITY OF COLORADO AT BOULDER CO $197,445
Lymphoma 2010 NCI 5K23CA124465-03 Novel Biologic Therapies for Hodgkin's Lymphoma KASAMON, YVETTE JOHNS HOPKINS UNIVERSITY MD $140,940
Lymphoma 2010 NCI 5R01CA093853-08 The role of p63 and p73 in cancer MOLL, UTE STATE UNIVERSITY NEW YORK STONY BROOK NY $314,296
Lymphoma 2010 NCI 5K23CA123149-04 Antigen Discovery and Development of Tumor-Specific Lymphoma Immunotherapy NEELAPU, SATTVA UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $136,080
Lymphoma 2010 NCI 5R01CA131024-02 The Role of Methylthioadenosine Phosphorylase Loss in Tumorigenesis KRUGER, WARREN FOX CHASE CANCER CENTER PA $362,088
Lymphoma 2010 NCI 7R01CA134451-02 Computer-assisted Grading and Risk Stratification of Follicular Lymphoma GURCAN, METIN OHIO STATE UNIVERSITY OH $315,904
Lymphoma 2010 NCI 5U10CA047559-20 Cancer and Leukemia Group B SHEA, THOMAS UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $164,588
Lymphoma 2010 NCI 5R01CA124309-05 Role of PML nuclear body proteins for establishment of EBV latent infection LING, PAUL BAYLOR COLLEGE OF MEDICINE TX $258,530
Lymphoma 2010 NCI 5R01CA122645-03 Rituximab Elicitation of Tumor Specific T-cell Responses in Lymphoma Patients BERNSTEIN, STEVEN UNIVERSITY OF ROCHESTER NY $317,913
Lymphoma 2010 NCI 5R21CA139368-02 Overcoming tumor cell resistance to apoptosis with a natural product, GCS-100 BAUM, LINDA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $169,400
Lymphoma 2010 NIDDK 5K01DK074555-06 Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2 JETTE, CICELY UNIVERSITY OF UTAH UT $133,110
Lymphoma 2010 NIBIB 5R01EB002991-07 Biofunctional Polymers for Intracellular Drug Delivery STAYTON, PATRICK UNIVERSITY OF WASHINGTON WA $513,659
Lymphoma 2010 NIBIB 5R01EB001994-11 SPECT/CT Image-Based Dosimetry in Radionuclide Tharapy DEWARAJA, YUNI UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $336,990
Lymphoma 2010 NCI 5R01CA068682-20 Biomedical Applications of Expanded Porphyrins SESSLER, JONATHAN UNIVERSITY OF TEXAS AUSTIN TX $305,354
Lymphoma 2010 NIDCR 5R01DE018304-04 ART Modulation of Viral Pathogenesis in Oral Epithelia DITTMER, DIRK UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $314,490
Lymphoma 2010 NHLBI 5R01HL076799-07 Inflammatory Proteases, Ubiquitin Proteasome System, and Myocyte Death SABRI, ABDELKARIM TEMPLE UNIVERSITY PA $375,000
Lymphoma 2010 NCI 5R01CA133063-03 Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY IL $274,204
Lymphoma 2010 NCI 5R01CA138268-02 Role of the cellular microRNA, miR-155, in EBV type III latency signaling FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $309,175
Lymphoma 2010 NCI 5K23CA113775-05 Proteosome Inhibition Therapy for Hematologic Malignancy HORTON, TERZAH BAYLOR COLLEGE OF MEDICINE TX $134,015
Lymphoma 2010 NCI 5R01CA058853-17 Regulation of EBV Infection in Epithelial Cells KENNEY, SHANNON UNIVERSITY OF WISCONSIN MADISON WI $293,684
Lymphoma 2010 NCI 5R01CA125195-04 Molecular Pathways in Suppression and Development of T Lineage Lymphomas BASSING, CRAIG CHILDRENS HOSPITAL OF PHILADELPHIA PA $312,550
Lymphoma 2010 NCI 5R01CA135531-03 Inflammation-regulated microRNA in B cell lymphoma RICKERT, ROBERT SANFORD-BURNHAM MEDICAL RESEARCH INSTIT CA $358,457
Lymphoma 2010 NCI 5R01CA121039-04 B Cell Lymphoma Therapy CHOI, YONG OCHSNER CLINIC FOUNDATION LA $244,245
Lymphoma 2010 NCI 5R21CA141094-02 Improved idiotype immunotherapy for lymphoma by RNA vaccine delivery MCCORMICK, ALISON TOURO UNIVERSITY OF CALIFORNIA CA $201,960
Lymphoma 2010 NCI 5R01CA132098-02 HDAC Inhibitors and CTCL SHOWE, LOUISE WISTAR INSTITUTE PA $406,113
Lymphoma 2010 NCI 5R01CA103642-07 Immune surveillance in murine gammaherpesvirus infection USHERWOOD, EDWARD DARTMOUTH COLLEGE NH $418,918
Lymphoma 2010 NCI 5R21CA133963-02 Murine Models for Mantle Cell Lymphoma: The role of tumor initiating cells (TIC) FORD, RICHARD UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $203,280
Lymphoma 2010 NIEHS 5R01ES015707-04 Comparative Mechanisms of Genomic Instability VASQUEZ, KAREN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $354,851
Lymphoma 2010 NCI 5R01CA096500-09 Role of KSHV K1 in viral pathogenesis DAMANIA, BLOSSOM UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $279,757
Lymphoma 2010 NIDCR 1R01DE019811-01A2 Cell Penetrating Helical Peptide Inhibitors of vFLIP K13 CHAUDHARY, PREET UNIVERSITY OF SOUTHERN CALIFORNIA CA $393,052
Lymphoma 2010 NCI 1R01CA149254-01 Antibody-CpG conjugates for the treatment of B cell lymphoma TIMMERMAN, JOHN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $319,550
Lymphoma 2010 NCI 5R37CA037295-27 AIDS Associated Lymphoproliferative Disorders DALLA-FAVERA, RICCARDO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $402,500
Lymphoma 2010 NCI 7R01CA085177-11 Role of orf-K13, an HHV8 Encoded vFLIP, in the Pathogenesis of AIDS-related Malig CHAUDHARY, PREET UNIVERSITY OF SOUTHERN CALIFORNIA CA $260,465
Lymphoma 2010 NCI 5R01CA134241-02 Post-Translational Events Underlying the KSHV vGPCR Pathogenesis FENG, PINGHUI UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $325,775
Lymphoma 2010 NCI 5R01CA108609-07 Anti-viral DC/NK interactions MUNZ, CHRISTIAN UNIVERSITY OF ZURICH SWITZE $182,434
Lymphoma 2010 NCI 1K08CA148821-01 The adoptive transfer of gene-modified T cells as a cell therapy for lymphoma DAVILA, MARCO SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $164,692
Lymphoma 2010 NIAID 5R01AI072194-02 ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO CHAUDHURI, JAYANTA SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $469,260
Lymphoma 2010 NCI 5R01CA092660-10 Lymphocyte Survival: Implications for lymphomagenesis THOMPSON, CRAIG UNIVERSITY OF PENNSYLVANIA PA $310,988
Lymphoma 2010 NIDCR 5R01DE018926-04 Pathogenesis of oral rhesus lymphocryptovirus infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $370,817
Lymphoma 2010 NCI 2U10CA016116-37 Eastern Cooperative Oncology Group FORASTIERE, ARLENE JOHNS HOPKINS UNIVERSITY MD $281,505
Lymphoma 2010 NCI 5R01CA131027-03 Chimeric T Cell for Therpay of Hodgkin Disease SAVOLDO, BARBARA BAYLOR COLLEGE OF MEDICINE TX $318,513
Lymphoma 2010 NCI 5R01CA047006-23 Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $571,286
Lymphoma 2010 NCI 5R03CA134159-02 Enhanced Self-Appraisal After Cancer: A Bias in Survivors' Self-Report? RECKLITIS, CHRISTOPHER DANA-FARBER CANCER INSTITUTE MA $85,203
Lymphoma 2010 NCI 5R01CA085180-10 Epstein-Barr Virus LMP-1 Mediated Oncongenicity KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $714,849
Lymphoma 2010 NCI 5R01CA068939-13 Survival Signals in AIDS Lymphomas CESARMAN, ETHEL WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $281,837
Lymphoma 2010 NCI 1R01CA149707-01 Investigating the functions of the miR-17~92 family of oncogenic microRNA cluster VENTURA, ANDREA SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $396,118
Lymphoma 2010 NCI 5R01CA139083-02 The Role of Interleukin-4 (IL-4) in the Pathogenesis of Non-Hodgkin's Lymphoma RUBENSTEIN, JAMES UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $319,743
Lymphoma 2010 NCI 1R01CA140245-01A1 Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction PALOMARES, MELANIE CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $709,292
Lymphoma 2010 NIAID 1R03AI083062-01A1 3-D Oral Mucosa Model for EBV Pathogenesis STOWE, RAYMOND MICROGEN, LLC TX $77,500
Lymphoma 2010 NCI 5R37CA057138-20 MYC ONCOPROTEIN FUNCTION EISENMAN, ROBERT FRED HUTCHINSON CANCER RESEARCH CENTER WA $853,968
Lymphoma 2010 NCI 1R15CA149690-01 Functions of Epstein-Barr Virus LMP2A in Latency SWANSON-MUNGERSON, MICHELLE MIDWESTERN UNIVERSITY IL $219,000
Lymphoma 2010 NCI 5R01CA122105-04 Prognostic Models in Diffuse Large B-Cell Lymphoma LOSSOS, IZIDORE UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $318,726
Lymphoma 2010 NIAID 5R01AI076972-04 Programming of CD8+ T Cell Tolerance by B Cell APC SCHOENBERGER, STEPHEN LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $453,692
Lymphoma 2010 NIDCR 5R01DE019249-03 Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma ELENITOBA-JOHNSON, KOJO UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $382,388
Lymphoma 2010 NIDCR 5R01DE017336-05 Epigenetic Regulation of Epstein-Barr Virus Latency Programs LIEBERMAN, PAUL WISTAR INSTITUTE PA $321,316
Lymphoma 2010 NCI 2R01CA104588-06 RAG-induced DNA damage: mechanisms and responses ROTH, DAVID NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $299,248
Lymphoma 2010 NCI 1R01CA140754-01A1 Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort JOHNSON, CHRISTINE C HENRY FORD HEALTH SYSTEM MI $692,432
Lymphoma 2010 NCI 5R01CA127530-03 The role of protein kinase PKK in BAFF signaling and B-cell malignancies ZHAO, JIYONG UNIVERSITY OF ROCHESTER NY $319,550
Lymphoma 2010 NCI 2P01CA090890-06A2 6522 Transplacental Chemoprevention of Lung Tumors and Lymphomas WILLIAMS, DAVID OREGON STATE UNIVERSITY OR $227,169
Lymphoma 2010 NCI 5R01CA056764-16 Activation of BCL-2 in Hematologic Malignancies BOXER, LINDA PALO ALTO INSTITUTE FOR RES & EDU, INC. CA $290,500
Lymphoma 2010 NIAID 5R01AI078980-02 Motor protein regulation of T cell receptor signaling POMERANTZ, JOEL JOHNS HOPKINS UNIVERSITY MD $405,900
Lymphoma 2010 NIAID 1R01AI081710-01A1 Mechanisms of KSHV post-transcriptional gene regulation CONRAD, NICHOLAS UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $314,000
Lymphoma 2010 NCI 5R01CA113454-05 Targeted Gene Therapy for Lymphoma SMITH, BRUCE AUBURN UNIVERSITY AT AUBURN AL $267,784
Lymphoma 2010 NCI 1R01CA138747-01A2 microRNA-155 and Lymphoma AGUIAR, RICARDO UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT TX $308,138
Lymphoma 2010 NIAID 2R01AI023283-25 Molecular Basis of Immunoglobulin Heavy Chain Switch STAVNEZER, JANET UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $458,803
Lymphoma 2010 NCI 1R01CA133571-01A2 Coordinately regulated alternative splicing in DNA damage and cancer CHANDLER, DAWN RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $268,920
Lymphoma 2010 NCI 1R21CA149978-01 Fractionated, Dual-targeted radioimmunotherapy for follicular lymphoma ELSTROM, REBECCA WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $350,675
Lymphoma 2010 NCI 1K07CA140360-01A1 Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma HUSSAIN, SHEHNAZ UNIVERSITY OF CALIFORNIA LOS ANGELES CA $122,504
Lymphoma 2010 NCI 5K07CA108565-05 QOL and Service Needs of Leukemia/Lymphoma Survivors PARRY, CARLA UNIVERSITY OF COLORADO DENVER CO $134,850
Lymphoma 2010 NCI 5R01CA093729-09 Repair of Genome Destabilizing DNA Structures VASQUEZ, KAREN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $307,161
Lymphoma 2010 NCI 5R01CA109335-05 Significance and Function of HGAL in Lymphoma LOSSOS, IZIDORE UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $250,696
Lymphoma 2010 NCI 5R01CA122663-05 A Genome-Wide Association Study of Non-Hodgkin Lymphoma SKIBOLA, CHRISTINE UNIVERSITY OF CALIFORNIA BERKELEY CA $508,204
Lymphoma 2010 NCI 1K08CA140780-01A1 Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB GEWURZ, BENJAMIN BRIGHAM AND WOMEN'S HOSPITAL MA $179,910
Lymphoma 2010 NCI 5R01CA085721-11 Experimental Therapy of Cancer by Costimulated Immunity CHEN, LIEPING JOHNS HOPKINS UNIVERSITY MD $325,256
Lymphoma 2010 NIAID 5R43AI078577-02 miRNA HD Array Platform SELIGMANN, BRUCE HIGH THROUGHPUT GENOMICS, INC. AZ $258,398
Lymphoma 2010 OD 1R03CA150037-01 Non-Hodgkin lymphoma in women: reproductive, hormonal and genetic factors BRACCI, PAIGE UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $77,250
Lymphoma 2010 NCI 1R03CA150070-01 Probiotic Metabolism of Rice Bran Phytochemicals for Chemoprevention RYAN, ELIZABETH COLORADO STATE UNIVERSITY-FORT COLLINS CO $73,500
Lymphoma 2010 NCI 5R01CA124540-03 Multiple Roles of the API2 Moiety in API2-MALT1-Mediated Lymphomagenesis MCALLISTER-LUCAS, LINDA UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $319,148
Lymphoma 2010 NIAID 5R01AI078267-02 Transcriptional Control of Hematopoiesis KEE, BARBARA UNIVERSITY OF CHICAGO IL $386,100
Lymphoma 2010 NCI 5R01CA092104-07 Biologic Therapy for B-cell non-Hodgkin's Lymphoma ANSELL, STEPHEN MAYO CLINIC MN $258,741
Lymphoma 2010 NCI 5R01CA137488-16 Two Compartment Models to Improve Brain Tumor Therapy NEUWELT, EDWARD OREGON HEALTH AND SCIENCE UNIVERSITY OR $490,363
Lymphoma 2010 NCI 5R01CA124596-03 Oncogenes and oncogenic microRNAs in chicken tumors BEEMON, KAREN JOHNS HOPKINS UNIVERSITY MD $334,992
Lymphoma 2010 NIAID 1R01AI084905-01A1 Regulation of B cell development by the proto-oncogene LRF/Pokemon MAEDA, TAKAHIRO CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $415,000
Lymphoma 2010 NCI 5R01CA128803-04 Identifying determinants of chemotherapeutic response in vivo HEMANN, MICHAEL MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $282,403
Lymphoma 2010 NCI 5R01CA121935-05 Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings BARBER, GLEN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $248,486
Lymphoma 2010 NCI 5R01CA127433-04 Signal transduction inhibitor therapy for Lymphoma WITZIG, THOMAS MAYO CLINIC MN $339,520
Lymphoma 2010 NCI 5R01CA090571-09 TCL1 Oncogene in B Lymphocyte Development and Neoplasia TEITELL, MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $266,199
Lymphoma 2010 NCI 7R01CA129962-03 Heat shock protein 90 antagonist-based therapy of mantle cell lymphoma BHALLA, KAPIL UNIVERSITY OF KANSAS MEDICAL CENTER KS $311,250
Lymphoma 2010 NCI 5R01CA112211-04 SPONTANEOUS CANINE MODELS FOR CANCER GENE DISCOVERY BREEN, MATTHEW NORTH CAROLINA STATE UNIVERSITY RALEIGH NC $282,300
Lymphoma 2010 NCI 5R01CA092153-08 Molecular Epidemiology of NHL and CLL CERHAN, JAMES MAYO CLINIC MN $626,174
Lymphoma 2010 NIAID 5K25AI079404-03 Light Weight Modeling of Epstein Barr Virus SHAPIRO, MICHAEL TUFTS UNIVERSITY BOSTON MA $124,632
Lymphoma 2010 NCI 5R01CA089194-10 Jak/STAT signaling in human T-cell lymphomas WASIK, MARIUSZ UNIVERSITY OF PENNSYLVANIA PA $249,891
Lymphoma 2010 NCI 5R01CA108872-05 Dysregulation of ubiquitination in MALT lymphomas YANG, XIAOLU UNIVERSITY OF PENNSYLVANIA PA $244,309
Lymphoma 2010 NIAID 5R43AI079928-02 Novel Inhibitors of Latent Epstein Barr Virus Infection MESSICK, TROY VIRONIKA, LLC PA $76,143
Lymphoma 2010 NCI 1R43CA150292-01 A novel in vivo test system to evaluate therapeutic antibodies in dog models of s HANSEN, GENEVIEVE VET THERAPEUTICS, INC. CA $154,000
Lymphoma 2010 NCI 5R13CA124293-05 Annual Primary CNS Lymphoma Collaborative Group Meeting BATCHELOR, TRACY MASSACHUSETTS GENERAL HOSPITAL MA $5,000
Lymphoma 2010 NCI 1F31CA150442-01 EBNA1 Functions Required in Burkitt's Lymphomas and Other Immortalized B-Cells WASHINGTON, AMBER LOUISIANA STATE UNIV HSC NEW ORLEANS LA $28,831
Lymphoma 2010 NHLBI 1F30HL103193-01 Adoptive cell therapy for lymphoma: A study on the role of CD4 memory T cells in GOLDSTEIN, MATTHEW STANFORD UNIVERSITY CA $30,710
Lymphoma 2010 NCI 5R01CA134234-03 Prognostic Markers for HIV-Postive Diffuse Large B-Cell Lymphoma CHAO, CHUN KAISER FOUNDATION RESEARCH INSTITUTE CA $357,589
Lymphoma 2010 NCI 5F32CA130469-03 The role of cellular miRNA in Epstein-Barr virus oncogenesis CAMERON, JENNIFER TULANE UNIVERSITY OF LOUISIANA LA $57,686
Lymphoma 2010 NCI 1F31CA150523-01 Role of HIV-1 Tat in the activation of HERV-K and development of HIV-1-lymphoma GONZALEZ-HERNANDEZ, MARTA UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $32,356
Lymphoma 2010 NCI 5R01CA122569-03 Toll Receptor Ligand Therapy of Cutaneous T-Cell Lymphoma ROOK, ALAIN UNIVERSITY OF PENNSYLVANIA PA $263,664
Lymphoma 2010 NCI 1F31CA150546-01 p53-independent function of Mdmx in tumorigenesis MELO, ALEXIA VANDERBILT UNIVERSITY TN $41,380
Lymphoma 2010 NCI 5R01CA116481-04 The Role of Fbxw7 in genetic instability and cancer MAO, JIAN-HUA UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB CA $355,982
Lymphoma 2010 NCI 5K08CA133521-02 Role of B-cell oncogenes and microRNA-34 in B-lymphopoiesis and neoplasia RAO, DINESH UNIVERSITY OF CALIFORNIA LOS ANGELES CA $155,209
Lymphoma 2010 NCI 5K08CA118260-05 CD20 DNA VACCINATION FOR B-CELL LYMPHOMA PALOMBA, MARIA SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $134,622
Lymphoma 2010 NCI 5K01CA122192-04 Cooperation of PTEN and SHIP as tumor suppressors in B-Cells PEDERSEN, IRENE UNIVERSITY OF CALIFORNIA SAN DIEGO CA $113,196
Lymphoma 2010 NCI 5K24CA128953-03 Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer ANTONIA, SCOTT H. LEE MOFFITT CANCER CTR & RES INST FL $167,791
Lymphoma 2010 NCRR 5R24RR023343-04 Herpesvirus latency and reactivation in macaque models of human disease ROSE, TIMOTHY SEATTLE CHILDREN'S HOSPITAL WA $609,484
Lymphoma 2010 NCI 5K08CA127353-03 Epigenetic Mechanisms of Lymphomagenesis. SHAKNOVICH, RITA WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $138,672
Lymphoma 2010 NCI 5R00CA125994-04 Combining Computational and Experimentation to Interrogate NF-kappaB Signaling COVERT, MARKUS STANFORD UNIVERSITY CA $249,000
Lymphoma 2010 NIAAA 5R01AA017972-02 Alcohol Consumption and Risk of NHL: Role of MTOR Dysfunction GARTENHAUS, RONALD UNIVERSITY OF MARYLAND BALTIMORE MD $352,688
Lymphoma 2010 NCI 5R01CA130826-03 Software & Hardware Inference Engines for Automated Determination of Primary Cell NOLAN, GARRY STANFORD UNIVERSITY CA $1,690,593
Lymphoma 2010 NCI 5R00CA131474-04 Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells NEILSON, JOEL BAYLOR COLLEGE OF MEDICINE TX $249,000
Lymphoma 2010 NIAID 1R41AI087167-01A1 Lipid Metabolism and KSHV-associated Lymphoma Pathogenesis PARSONS, CHRISTOPHER APOGEE BIOTECHNOLOGY CORPORATION PA $300,000
Lymphoma 2010 NCI 5K08CA140718-02 Regulation and Dysregulation of Antibody Diversification STROUT, MATTHEW YALE UNIVERSITY CT $174,420
Lymphoma 2010 NCI 1R03CA151153-01 Racial Disparities in Clinical Outcomes and the Therapeutic Use of Radiotherapy f WILSON, LYNN YALE UNIVERSITY CT $82,750
Lymphoma 2010 NCI 5R01CA112217-05 Targeting of EBV Latency in Burkitt's Lymphoma RAMOS, JUAN CARLOS UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $236,524
Lymphoma 2010 NIAID 5R21AI081224-02 Long-Range Genetic and Epigenetic Control of Tcrb Gene Assembly OLTZ, EUGENE WASHINGTON UNIVERSITY MO $225,720
Lymphoma 2010 NIAID 5R01AI085024-02 Gene and Cytokine Expression in Tolerance and GVHD SARWAL, MINNIE STANFORD UNIVERSITY CA $396,000
Lymphoma 2010 NIAID 5R01AI078234-02 New Strategies to Decipher the Pathophysiology of Chronic Fatigue Syndrome MIKOVITS, JUDY WHITTEMORE PETERSON INSTITUTE NV $322,097
Lymphoma 2010 NCI 5K99CA140728-02 Immunotransplant to Treat Lymphoma: Pre-Clinical Model to Clinical Trial Design BRODY, JOSHUA STANFORD UNIVERSITY CA $173,448
Lymphoma 2010 NCI 5K01CA138559-02 Antibody-mediated Gene Therapy for the Treatment of Cancer DANIELS, TRACY UNIVERSITY OF CALIFORNIA LOS ANGELES CA $139,465
Lymphoma 2010 NIAID 1R01AI089882-01 Molecular elucidation of the CBM complex in NF-kappaB activation by antigen recep WU, HAO WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $380,250
Lymphoma 2010 NCI 1R01CA151955-01 A bifunctional nanomedicine for both specific imaging and targeting therapy of an ZU, YOULI METHODIST HOSPITAL RESEARCH INSTITUTE TX $319,550
Lymphoma 2010 NCI 1R01CA152212-01 Discover and Engineer New Histone Deacetylase Inhibitors as Anticancer Agents CHENG, YI-QIANG UNIVERSITY OF WISCONSIN MILWAUKEE WI $224,873
Lymphoma 2010 NCI 1K99CA151827-01 ROLE OF REPLICATION STRESS DURING MYC-DEPENDENT LYMPHOMAGENESIS DOMINGUEZ-SOLA, DAVID COLUMBIA UNIVERSITY HEALTH SCIENCES NY $141,376
Lymphoma 2010 NCI 1R01CA139119-01A2 A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera CHAUDHARY, PREET UNIVERSITY OF SOUTHERN CALIFORNIA CA $268,920
Lymphoma 2010 NCI 1R21CA152858-01 PREDICTING OUTCOME OF EXPERIMENTAL THERAPY IN LYMPHOMAS BY 31P & 1H MRS ARIAS-MENDOZA, FERNANDO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $184,886
Lymphoma 2010 NCI 5F32CA139868-02 Development of a Pd Catalyzed 3+2 Annulation and Synthesis of Daphnicyclidin B MANNING, JAMES UNIVERSITY OF CALIFORNIA IRVINE CA $50,474
Lymphoma 2010 NHLBI 1R01HL094603-01A1 Chronic High EBV load and risk of PTLD in Pediatric Heart Transplant Patients METES, DIANA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $369,995
Lymphoma 2010 NCI 2R01CA072649-12A2 Somatic Mutation of IG Variable Regions SCHARFF, MATTHEW ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $407,020
Lymphoma 2010 NCI 1R01CA142809-01A1 Signal Transduction Pathways in CD30-positive Lymphomas DUCKETT, COLIN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $137,479
Lymphoma 2010 NIAID 1R01AI087634-01A1 The Role of miR-17~92 in Autoimmune Diseases XIAO, CHANGCHUN SCRIPPS RESEARCH INSTITUTE CA $427,275
Lymphoma 2010 NCI 9R01CA153260-11A2 Control of Lineage Commitment in Developing Thymocytes KAPPES, DIETMAR INSTITUTE FOR CANCER RESEARCH PA $203,413
Lymphoma 2010 NCI 3R01CA120439-04S1 Small Molecule Activators of Procaspases as Anti-cancer Agents HERGENROTHER, PAUL UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN IL $263,110
Lymphoma 2010 NIAID 2R01AI063058-06A1 Mechanism and regulation of DNA end processing in V(D)J recombination and repair SEKIGUCHI, JOANN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $346,666
Lymphoma 2010 NCI 2R01CA102667-06A1 Effects of Malaria on EBV Persistence in Children ROCHFORD, ROSEMARY UPSTATE MEDICAL UNIVERSITY NY $155,834
Lymphoma 2010 OD 2R01CA102667-06A1 Effects of Malaria on EBV Persistence in Children ROCHFORD, ROSEMARY UPSTATE MEDICAL UNIVERSITY NY $155,832
Lymphoma 2010 NCI 2R01CA104348-06A2 Transcriptional silencing by the BCL6 oncoprotein MELNICK, ARI WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $268,277
Lymphoma 2010 NCI 1K23CA140722-01A1 Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma FAN, ALICE STANFORD UNIVERSITY CA $173,448
Lymphoma 2010 NCI 1R03CA143947-01A1 Energy balance and nutrigenetic analysis of non-Hodgkin lymphoma BRACCI, PAIGE UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $77,250
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer